We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Philips Healthcare Expands Business in Emerging Markets with Indian Acquisition

By MedImaging International staff writers
Posted on 06 Oct 2008
Print article
Philips Healthcare (Best, The Netherlands) announced it has reached an agreement to acquire Alpha X-Ray Technologies (Mumbai, India), a leading manufacturer of cardiovascular X-ray systems targeting the economy segment of the Indian market.

Upon closing of this transaction in the fourth quarter of 2008, which is subject to certain contractual and other conditions such as regulatory approvals, Alpha will become part of the cardiovascular X-ray business within Philips' Healthcare sector. Financial details of this agreement were not disclosed.

The announcement marks Philips' strong presence in high-growth healthcare market in emerging economies, and follows the earlier acquisitions of healthcare companies Brazilian Dixtal Biomédica e Tecnologia, Shenzhen Goldway Industrial in China, and VMI Sistemas Medicos in Brazil. In commenting on the acquisition, Ronald de Jong, CEO Emerging Markets of Philips Healthcare, said, "The acquisition of Alpha is another great example of how Philips continues to strengthen its industrial and commercial footprint in emerging markets. It provides us with significant presence in the high-growth economy segment for cardiovascular X-ray systems, underlining our commitment to deliver affordable healthcare solutions in emerging markets.”

Alpha's economy segment product range complements Philips' existing cardiovascular X-ray range and helps Philips to capture an even larger slice of the global EUR 1.8 billion cardiovascular X-ray market. Analysts estimate that the economy segment is the fastest growing segment of the global cardiovascular X-ray market, with anticipated annual growth rates of 10-15% in coming years. Philips will leverage its global distribution network to sell Alpha's cardiovascular X-ray products, thereby maximizing the value of the acquisition and adding another growth engine to Philips Healthcare's emerging markets business.

"The addition of Alpha represents another significant addition to our emerging markets healthcare product portfolio, and comes on the heels of two key product introductions in India: the SureSigns VM3 patient monitor and the cost-effective ultrasound HD15 system,” said Murali Sivaraman, CEO of Philips Electronics India, Ltd. "Furthermore, this acquisition highlights the pivotal role India plays in Philips' emerging markets growth strategy. Going forward, we are committed to leverage both organic and inorganic opportunities to drive growth in India,” Mr. Sivaraman added.

Alpha X-Ray Technologies is a leading cardiovascular X-ray manufacturer in India. Alpha manufactures X-ray systems and components for the economy segment of the global cardiovascular X-ray market.

Related Links:
Philips Healthcare
Alpha X-Ray Technologies

New
High-Precision QA Tool
DEXA Phantom
New
Needle Guide Disposable Kit
Verza
3T MRI Scanner
MAGNETOM Cima.X
New
Medical Radiographic X-Ray Machine
TR30N HF

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.